Biomarkers of Ageing, Explained: What Biological Age Tests Can and Cannot Tell You
20 September 2026 · 8 min read
Biological age tests are among the most searched longevity products in the United States. But what do these tests actually measure, how reliable are they, and why do researchers say the field still lacks validated standards? This guide separates the promising science from the marketing.
What a biomarker of ageing is
A biomarker of ageing is a measurable characteristic that tracks biological ageing better than the date on your passport. Chronological age is fixed. Biological age, in principle, reflects how quickly your tissues and systems are accumulating damage, and it may respond to lifestyle, disease and potentially to interventions.
Good biomarkers matter because clinical trials of longevity interventions cannot wait decades for outcomes. If a validated marker moved reliably within months, researchers could test whether a treatment slows ageing far faster and more cheaply than traditional trials allow.
The main types in use today
Epigenetic clocks are the best known. First developed by Steve Horvath at UCLA in 2013, they estimate biological age from chemical marks on DNA called methylation. Later clocks, such as GrimAge and DunedinPACE, were trained to predict health outcomes and pace of ageing rather than chronological age, and they correlate with mortality and disease risk in large cohorts.
Other approaches use blood chemistry panels, immune cell profiles, proteomics, imaging and wearable-derived measures such as heart rate variability. Each captures a different slice of biology. None, on its own, captures ageing as a whole.
What the tests can and cannot tell you
What they can do, in research settings: distinguish faster from slower agers at population level, and flag elevated risk before disease appears. A 2023 study in Nature Aging linked proteomic ageing signatures to future disease risk across thousands of participants.
What they cannot yet do: give an individual a precise, actionable biological age. Test-retest variation between samples from the same person can be large, different commercial tests often disagree, and there is no consensus that changing a test score means you have changed your underlying health trajectory. The Biomarkers of Aging Consortium, a community of leading researchers, exists precisely to fix this through validation and standardisation.
How to read the marketing
Treat any test sold with promises of reversing ageing as unsupported. The credible position, shared by academic groups and the consortium, is that these measures are promising research tools moving towards clinical utility, not yet proven guides for individual decisions.
If you do take a test, interpret it alongside conventional measures with strong evidence, blood pressure, lipids, glucose control, fitness and sleep, and discuss results with a clinician. That combination reflects where the science genuinely stands.
This article is for general information only and is not medical advice. Decisions about your health should be made with a qualified clinician.